…also reported on vaccine trials for a number of other conditions, including Nipah virus, rabies and lung cancer. You can listen below, or find The Drug Discovery World Podcast on…
…treatments of other skeletal disorders.” The FDA granted Orphan Drug Designation for SIS-101-ADO in May 2023, as well as Rare Paediatric Disease Designation for the treatment of Autosomal Dominant Osteopetrosis….
News round-up for 18-22 September by DDW Digital Content Editor Diana Spencer. As we approach another autumn/winter season in the northern hemisphere, Covid-19 vaccines are once again making the headlines,…
…a useful biomarker for disease progression. Potential drug targets to be investigated Robin Dart, former Wellcome trust funded PhD student at the Crick, postdoctoral clinical research fellow at King’s College…
…setting. They found that by reducing MEG3 and preventing necroptosis, researchers could in turn prevent the death of cells. “Necroptosis is already an active area of drug development in cancer…
Created by DDW and sponsored by Tecan, ‘The Rise of NGS and its impact on drug discovery’ is a free In Focus report available here. Download this In Focus eReport…
…and ML are transforming drug discovery How to program novel medicines to treat a variety of diseases How our AI platform is learning at unprecedented speed and scale …
…Seahorse XF Real Time ATP rate assay provides a simple robust workflow that can identify metabolic targets for drug discovery. How it can identify metabolic target pathways to be investigated…
…platform plays in realising the full value of data-driven drug discovery and development. He will walk through the three critical functions that Proscia’s enterprise pathology platform, Concentriq, performs in putting…
…OneLab software to create integrated and easy-to-use bioprocess walk-up solutions. It is designed to enable less experienced LC-MS users to acquire critical quality attribute (CQA) data for analysis of drug…
…of drug and gene therapies’ will take place on 28 September 4PM BST, 5PM CEST, EDT 11AM, PDT 8AM. Register for free here. Speakers: Chris Kirton, Chief Executive Officer, DefiniGEN…
…ML are transforming drug discovery How to program novel medicines to treat a variety of diseases How our AI platform is learning at unprecedented speed and scale Register here to…
…with its first-in-class lead molecule, satoreotide, targeting extensive stage small cell lung cancer (ES-SCLC). £1.8 million raised to accelerate quantum drug discovery Kuano, a drug discovery company combining quantum mechanics…
…insight and accelerating drug discovery with AI. He will walk through the three critical functions that Proscia’s enterprise pathology platform, Concentriq, performs in putting computational solutions into practice. What you…
Orano Med, a biotechnology company developing Lead-212 (212Pb) targeted alpha therapy against cancer, and Orbit Discovery, a company discovering therapeutic peptide hits, have entered into a collaboration to discover specific…
